Sort   by:  
 Page size 
UnknownReal-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United States.
Not available
S-EPMC5911510 | biostudies-literature
UnknownThe Urticaria Voices Study: Physicians' Perspectives on the Real-World Patient Burden, Treatments, and Outcomes in Chronic Spontaneous Urticaria.
Not available
S-EPMC12454223 | biostudies-literature
UnknownSafety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial.
Not available
S-EPMC8713509 | biostudies-literature
UnknownA cross-sectional questionnaire assessing patient and physician use of short-term prophylaxis for hereditary angioedema.
Not available
S-EPMC4141470 | biostudies-literature
UnknownCannabis-related allergies: An international overview and consensus recommendations.
Not available
S-EPMC9871863 | biostudies-literature
UnknownIdentification of a novel mutation in the APTX gene associated with ataxia-oculomotor apraxia.
Not available
S-EPMC5701303 | biostudies-literature
UnknownDevelopment and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria.
Not available
S-EPMC5440910 | biostudies-literature
UnknownWhy is it so hard to implement change? A qualitative examination of barriers and facilitators to distribution of naloxone for overdose prevention in a safety net environment.
Not available
S-EPMC5070095 | biostudies-literature
UnknownAssessing Preferences of Patients with Chronic Spontaneous Urticaria for Injectable Treatment Profiles.
Not available
S-EPMC11832561 | biostudies-literature
Unknown"It seems like COVID-19 now is the only disease present on Earth": living with a rare or undiagnosed disease during the COVID-19 pandemic.
Not available
S-EPMC7792915 | biostudies-literature
Sort   by:  
 Page size